Enteral iron supplementation up to 60 days of life in preterm infants is associated with neurodevelopmental outcome at 2 years: a secondary analysis of NICHD Neonatal Research Network Darbe Trial
Saturday, April 26, 2025
7:00am – 7:15am HST
Location: Convention Center: Kalākaua Ballroom B (Level 4)
Timothy M. Bahr, University of Utah, Provo, UT, United States; Sylvia M. Tan, RTI International, Washington, DC, United States; Sandra Beauman, University of New Mexico, Albuquerque, NM, United States; Kurt Schibler, Cincinnati Children's Hospital Medical Center, Loveland, OH, United States; Cathy Grisby, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Jean R. Lowe, University of New Mexico School of Medicine, Albuquerque NM, NM, United States; Edward F. Bell, University of Iowa, Iowa City, IA, United States; Abbot Laptook, Women & Infants Hospital of Rhode Island, Providence, RI, United States; Seetha Shankaran, The University of Texas at Austin, Ann Arbor, MI, United States; David P. Carlton, Emory University School of Medicine, Atlanta, GA, United States; Mariana Baserga, University of Utah School of Medicine, Salt lake City, UT, United States; John Flibotte, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Kristin Zaterka-Baxter, RTI International, RTP, NC, United States; Abhik Das, RTI International, North Potomac, MD, United States; Robert Christensen, University of Utah School of Medicine, Salt Lake City, UT, United States; Robin K. Ohls, University of Utah, Salt Lake City, UT, United States; NICHD Neonatal Research Network, National Institute of Child Health and Human Development, Bethesda, MD, United States
Presenting Author(s)
Timothy M. Bahr, MD (he/him/his)
Assistant Professor of Pediatrics University of Utah Provo, Utah, United States
Disclosure(s):
Timothy M. Bahr, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.